Cytek Biosciences grants RSUs and options to CLO
Cytek Biosciences, Inc. granted Chief Legal Officer and Secretary Ilan Feuchtwang new equity awards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Cytek Biosciences, Inc. granted Chief Legal Officer and Secretary Ilan Feuchtwang new equity awards. The awards consist of 241,416 Restricted Stock Units, each representing one share of common stock, and an option for 127,118 shares of common stock at an exercise price of $4.66 per share, expiring on August 9, 2036. The RSUs and options vest over four years under specified installment schedules, in each case subject to the executive’s Continuous Service under the company’s 2021 Equity Incentive Plan.
Insider Trade Summary
Grant/Award: 368,534 shares
Grant/Award
2 txns
Insider
Feuchtwang Ilan
Role
Chief Legal Officer, Secretary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units F1, F2 | 241,416 | $0.00 | $0.00 |
| Grant/Award | Employee Stock Option (right to buy) F3 | 127,118 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 241,416 contracts (Direct);
Employee Stock Option (right to buy) — 127,118 contracts (Direct)
Footnotes (3)
- F1. Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.
- F2. The RSUs shall vest and settle into common stock over 4 years, with 12/48 of the RSUs vesting on August 18, 2027; 3/48 of the RSUs vesting on November 18, 2027 and each November 18 thereafter; 4/48 of the RSUs vesting on March 10, 2028 and each March 10 thereafter; 2/48 of the RSUs vesting on May 18, 2028 and each May 18 thereafter; and 3/48 of the RSUs vesting on August 18, 2028 and each August 18 thereafter, until fully vested (in each case, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Invesntive Plan (the "2021 Plan"))).
- F3. The shares subject to the option shall vest over 4 years with 25% vesting on August 10, 2027 and 1/48 of the shares vesting each month thereafter, until fully vested (in each case, subject to the Reporting Person's Continuous Service (as defined in the 2021 Plan)).
Key Figures
RSUs granted: 241,416 units
Options granted: 127,118 shares
Option exercise price: $4.66 per share
+5 more
8 metrics
RSUs granted
241,416 units
Restricted Stock Units representing common stock granted to Ilan Feuchtwang on August 10, 2026
Options granted
127,118 shares
Employee stock option for common stock granted on August 10, 2026
Option exercise price
$4.66 per share
Exercise price for 127,118-share employee stock option expiring August 9, 2036
Option expiration date
August 9, 2036
Expiration of employee stock option for 127,118 shares of common stock
RSUs following transaction
241,416 units
Total RSUs held directly after the grant transaction
Options following transaction
127,118 shares
Total option shares held directly after the grant transaction
Initial RSU vest date
August 18, 2027
12/48 of the RSUs vest on this date, subject to Continuous Service
Initial option vest date
August 10, 2027
25% of the option shares vest on this date, with monthly vesting thereafter
Key Terms
Restricted Stock Units, Employee Stock Option, Continuous Service, 2021 Equity Incentive Plan
4 terms
Restricted Stock Units financial
"Each restricted stock unit (the "RSU") represents a contingent right"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Employee Stock Option financial
"The shares subject to the option shall vest over 4 years"
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
Continuous Service financial
"subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2021"
2021 Equity Incentive Plan financial
"as defined in the Issuer's 2021 Equity Invesntive Plan (the "2021 Plan")"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Cytek Biosciences (CTKB) grant to Ilan Feuchtwang?
Cytek Biosciences granted Ilan Feuchtwang 241,416 RSUs and an employee stock option for 127,118 shares of common stock at an exercise price of $4.66 per share, both vesting over four years.
How many Cytek Biosciences (CTKB) RSUs were awarded and how do they vest?
Ilan Feuchtwang received 241,416 RSUs, each for one share of common stock. They vest over four years in multiple scheduled tranches beginning on August 18, 2027, subject to his Continuous Service under the 2021 Equity Incentive Plan.
What are the key terms of the Cytek Biosciences (CTKB) stock option grant?
The employee stock option covers 127,118 shares of common stock at an exercise price of $4.66 per share. It vests over four years, starting with 25% on August 10, 2027, and expires on August 9, 2036.
When do Ilan Feuchtwang’s Cytek Biosciences (CTKB) RSUs begin vesting?
The RSUs begin vesting on August 18, 2027, when 12/48 of the 241,416 RSUs vest. Additional installments vest on specified dates in November, March, May, and August each year, subject to Continuous Service.
What does Continuous Service mean for Cytek Biosciences (CTKB) equity vesting?
Both the 241,416 RSUs and the option for 127,118 shares vest only while Ilan Feuchtwang maintains Continuous Service, as defined in Cytek’s 2021 Equity Incentive Plan, meaning ongoing qualifying service with the company.
AI-generated analysis. How Rhea-AI works. Not financial advice.
